Eng M. Tan - Publications

Molecular and Experimental Medicine Scripps Research Institute, La Jolla, La Jolla, CA, United States 

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Dai L, Tsay JC, Li J, Yie TA, Munger JS, Pass H, Rom WN, Zhang Y, Tan EM, Zhang JY. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Lung Cancer (Amsterdam, Netherlands). 99: 172-9. PMID 27565936 DOI: 10.1016/j.lungcan.2016.07.018  0.52
2014 Dai L, Ren P, Liu M, Imai H, Tan EM, Zhang JY. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Clinical Immunology (Orlando, Fla.). 152: 127-39. PMID 24667685 DOI: 10.1016/j.clim.2014.03.007  0.52
2014 Tan EM. Antinuclear antibodies defining autoimmunity pathways. Arthritis Research & Therapy. 16: 104. PMID 24517467 DOI: 10.1186/ar4482  0.52
2012 Tan EM. Autoantibodies, autoimmune disease, and the birth of immune diagnostics. The Journal of Clinical Investigation. 122: 3835-6. PMID 23154275 DOI: 10.1172/JCI66510  0.52
2011 Tybl E, Shi FD, Kessler SM, Tierling S, Walter J, Bohle RM, Wieland S, Zhang J, Tan EM, Kiemer AK. Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. Journal of Hepatology. 54: 994-1001. PMID 21145819 DOI: 10.1016/j.jhep.2010.08.034  0.52
2010 Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, Vergani D, Bogdanos DP, Dalekos GN, Milkiewicz P, Czaja AJ, Heathcote EJ, Hirschfield GM, Tan EM, Miyachi K, et al. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. Journal of Autoimmunity. 35: 436-42. PMID 20932720 DOI: 10.1016/j.jaut.2010.09.005  0.52
2010 Rom WN, Goldberg JD, Addrizzo-Harris D, Watson HN, Khilkin M, Greenberg AK, Naidich DP, Crawford B, Eylers E, Liu D, Tan EM. Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers. Bmc Cancer. 10: 234. PMID 20504322 DOI: 10.1186/1471-2407-10-234  0.52
2010 Zhang JY, Tan EM. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Review of Molecular Diagnostics. 10: 321-8. PMID 20370589 DOI: 10.1586/erm.10.12  0.52
2010 Chen Y, Zhou Y, Qiu S, Wang K, Liu S, Peng XX, Li J, Tan EM, Zhang JY. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Letters. 289: 32-9. PMID 19683863 DOI: 10.1016/j.canlet.2009.07.016  0.52
2009 Zhang JY, Looi KS, Tan EM. Identification of tumor-associated antigens as diagnostic and predictive biomarkers in cancer. Methods in Molecular Biology (Clifton, N.J.). 520: 1-10. PMID 19381943 DOI: 10.1007/978-1-60327-811-9_1  0.52
2008 Looi KS, Nakayasu ES, Diaz RA, Tan EM, Almeida IC, Zhang JY. Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. Journal of Proteome Research. 7: 4004-12. PMID 18672925 DOI: 10.1021/pr800273h  0.52
2008 Tan EM, Zhang J. Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunological Reviews. 222: 328-40. PMID 18364012 DOI: 10.1111/j.1600-065X.2008.00611.x  0.52
2007 Ersvaer E, Zhang JY, McCormack E, Olsnes A, Anensen N, Tan EM, Gjertsen BT, Bruserud O. Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients. European Journal of Haematology. 79: 210-25. PMID 17655707 DOI: 10.1111/j.1600-0609.2007.00899.x  0.52
2007 Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EK. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. Journal of Hepatology. 46: 107-14. PMID 17067715 DOI: 10.1016/j.jhep.2006.08.010  0.52
2006 Casiano CA, Mediavilla-Varela M, Tan EM. Tumor-associated antigen arrays for the serological diagnosis of cancer. Molecular & Cellular Proteomics : McP. 5: 1745-59. PMID 16733262 DOI: 10.1074/mcp.R600010-MCP200  0.52
2006 Tan EM, Kunkel HG. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J. Immunol. 1966. 96: 464-471. Journal of Immunology (Baltimore, Md. : 1950). 176: 1297-304. PMID 16424153  1
2005 Lu Y, Ye P, Chen SL, Tan EM, Chan EK. Identification of kinectin as a novel Behçet's disease autoantigen. Arthritis Research & Therapy. 7: R1133-9. PMID 16207330 DOI: 10.1186/ar1798  0.52
2005 Himoto T, Kuriyama S, Zhang JY, Chan EK, Kimura Y, Masaki T, Uchida N, Nishioka M, Tan EM. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma. International Journal of Oncology. 27: 1079-85. PMID 16142326  0.52
2005 Megliorino R, Shi FD, Peng XX, Wang X, Chan EK, Tan EM, Zhang JY. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection. Cancer Detection and Prevention. 29: 241-8. PMID 15896923 DOI: 10.1016/j.cdp.2005.03.002  0.52
2005 Himoto T, Kuriyama S, Zhang JY, Chan EK, Nishioka M, Tan EM. Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma. International Journal of Oncology. 26: 311-7. PMID 15645114  0.52
2005 Shi FD, Zhang JY, Liu D, Rearden A, Elliot M, Nachtsheim D, Daniels T, Casiano CA, Heeb MJ, Chan EK, Tan EM. Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. The Prostate. 63: 252-8. PMID 15538718 DOI: 10.1002/pros.20181  0.52
2004 Williams RC, Sugiura K, Tan EM. Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. Arthritis and Rheumatism. 50: 1239-47. PMID 15077307 DOI: 10.1002/art.20156  0.52
2004 Watanabe A, Kodera M, Sugiura K, Usuda T, Tan EM, Takasaki Y, Tomita Y, Muro Y. Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis and Rheumatism. 50: 892-900. PMID 15022332 DOI: 10.1002/art.20096  0.52
2003 Fritzler MJ, Wiik A, Tan EM, Smolen JS, McDougal JS, Chan EK, Gordon TP, Hardin JA, Kalden JR, Lahita RG, Maini RN, Reeves WH, Rothfield NF, Takasaki Y, Wilson M, et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. The Journal of Rheumatology. 30: 2374-81. PMID 14677180  0.52
2003 Koziol JA, Zhang JY, Casiano CA, Peng XX, Shi FD, Feng AC, Chan EK, Tan EM. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 5120-6. PMID 14613989  0.52
2003 Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EK, Tan EM. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 136-43. PMID 12582023  0.52
2002 Tan EM, Sugiura K, Gupta S. The case definition of chronic fatigue syndrome. Journal of Clinical Immunology. 22: 8-12. PMID 11958593 DOI: 10.1023/A:1014248301721  0.52
2002 Tan EM, Smolen JS, McDougal JS, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, Reeves WH, Rothfield NF, Takasaki Y, Wiik A, Wilson M, Koziol JA. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content. The Journal of Rheumatology. 29: 68-74. PMID 11824974  0.52
1999 Erlanson M, Casiano CA, Tan EM, Lindh J, Roos G, Landberg G. Immunohistochemical analysis of the proliferation associated nuclear antigen CENP-F in non-Hodgkin's lymphoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 12: 69-74. PMID 9950165  0.52
1998 Casiano CA, Ochs RL, Tan EM. Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death and Differentiation. 5: 183-90. PMID 10200463 DOI: 10.1038/sj.cdd.4400336  0.52
1997 Rattner JB, Rees J, Whitehead CM, Casiano CA, Tan EM, Humbel RL, Conrad K, Fritzler MJ. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clinical and Investigative Medicine. MéDecine Clinique Et Experimentale. 20: 308-19. PMID 9336656  0.52
1997 Pollard KM, Lee DK, Casiano CA, Bluthner M, Johnston MM, Tan EM. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. Journal of Immunology (Baltimore, Md. : 1950). 158: 3521-8. PMID 9120314  0.52
1996 Casiano CA, Tan EM. Antinuclear autoantibodies: probes for defining proteolytic events associated with apoptosis. Molecular Biology Reports. 23: 211-6. PMID 9112231  0.52
1996 Casiano CA, Tan EM. Recent developments in the understanding of antinuclear autoantibodies. International Archives of Allergy and Immunology. 111: 308-13. PMID 8957101  0.52
1996 Landberg G, Erlanson M, Roos G, Tan EM, Casiano CA. Nuclear autoantigen p330d/CENP-F: a marker for cell proliferation in human malignancies. Cytometry. 25: 90-8. PMID 8875058 DOI: 10.1002/(SICI)1097-0320(19960901)25:1<90::AID-CYTO10>3.0.CO;2-P  0.52
1996 Casiano CA, Martin SJ, Green DR, Tan EM. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. The Journal of Experimental Medicine. 184: 765-70. PMID 8760832  0.52
1996 Báez A, Torres K, Tan EM, Pommier Y, Casiano CA. Expression of proliferation-associated nuclear autoantigens, p330d/CENP-F and PCNA, in differentiation and in drug-induced growth inhibition using two-parameter flow cytometry. Cell Proliferation. 29: 183-96. PMID 8695747  0.52
1996 Martin SJ, Amarante-Mendes GP, Shi L, Chuang TH, Casiano CA, O'Brien GA, Fitzgerald P, Tan EM, Bokoch GM, Greenberg AH, Green DR. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism. The Embo Journal. 15: 2407-16. PMID 8665848  0.52
1995 Casiano CA, Humbel RL, Peebles C, Covini G, Tan EM. Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation. Journal of Autoimmunity. 8: 575-86. PMID 7492351 DOI: 10.1016/0896-8411(95)90009-8  0.52
1993 Casiano CA, Landberg G, Ochs RL, Tan EM. Autoantibodies to a novel cell cycle-regulated protein that accumulates in the nuclear matrix during S phase and is localized in the kinetochores and spindle midzone during mitosis. Journal of Cell Science. 106: 1045-56. PMID 7907337  0.52
1977 Tan EM, Christian C, Holman HR, Homma M, Kunkel HG, Reichlin M, Sharp GC, Ziff M, Barnett EV. Anti-tissue antibodies in rheumatic disease: standardization and nomenclature. Arthritis and Rheumatism. 20: 1419-20. PMID 303105  0.52
1966 Tan EM, Kunkel HG. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. Journal of Immunology (Baltimore, Md. : 1950). 96: 464-71. PMID 5932578  1
1966 Tan EM, Schur PH, Carr RI, Kunkel HG. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. The Journal of Clinical Investigation. 45: 1732-40. PMID 4959277 DOI: 10.1172/JCI105479  1
1966 Tan EM, Kunkel HG. An immunofluorescent study of the skin lesions in systemic lupus erythematosus. Arthritis and Rheumatism. 9: 37-46. PMID 4143707  1
1964 KUNKEL HG, TAN EM. AUTOANTIBODIES AND DISEASE. Advances in Immunology. 27: 351-95. PMID 14333021  1
Show low-probability matches.